Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vicky A. Newman is active.

Publication


Featured researches published by Vicky A. Newman.


Journal of Clinical Oncology | 2007

Greater Survival After Breast Cancer in Physically Active Women With High Vegetable-Fruit Intake Regardless of Obesity

John P. Pierce; Marcia L. Stefanick; Shirley W. Flatt; Loki Natarajan; Barbara Sternfeld; Lisa Madlensky; Wael K. Al-Delaimy; Cynthia A. Thomson; Sheila Kealey; Richard A. Hajek; Barbara A. Parker; Vicky A. Newman; Bette Caan; Cheryl L. Rock

PURPOSE Single-variable analyses have associated physical activity, diet, and obesity with survival after breast cancer. This report investigates interactions among these variables. PATIENTS AND METHODS A prospective study was performed of 1,490 women diagnosed and treated for early-stage breast cancer between 1991 and 2000. Enrollment was an average of 2 years postdiagnosis. Only seven women were lost to follow-up through December 2005. RESULTS In univariate analysis, reduced mortality was weakly associated with higher vegetable-fruit consumption, increased physical activity, and a body mass index that was neither low weight nor obese. In a multivariate Cox model, only the combination of consuming five or more daily servings of vegetables-fruits, and accumulating 540+ metabolic equivalent tasks-min/wk (equivalent to walking 30 minutes 6 d/wk), was associated with a significant survival advantage (hazard ratio, 0.56; 95% CI, 0.31 to 0.98). The approximate 50% reduction in risk associated with these healthy lifestyle behaviors was observed in both obese and nonobese women, although fewer obese women were physically active with a healthy dietary pattern (16% v 30%). Among those who adhered to this healthy lifestyle, there was no apparent effect of obesity on survival. The effect was stronger in women who had hormone receptor-positive cancers. CONCLUSION A minority of breast cancer survivors follow a healthy lifestyle that includes both recommended intakes of vegetables-fruits and moderate levels of physical activity. The strong protective effect observed suggests a need for additional investigation of the effect of the combined influence of diet and physical activity on breast cancer survival.


Controlled Clinical Trials | 2002

A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study

John P. Pierce; Susan Faerber; Fred A. Wright; Cheryl L. Rock; Vicky A. Newman; Shirley W. Flatt; Sheila Kealey; Vicky Jones; Bette J. Caan; Ellen B. Gold; Mary N. Haan; Kathryn A. Hollenbach; Lovell A. Jones; James R. Marshall; Cheryl Ritenbaugh; Marcia L. Stefanick; Cynthia A. Thomson; Linda Wasserman; Loki Natarajan; Ronald G. Thomas; Elizabeth A. Gilpin

The Womens Healthy Eating and Living (WHEL) Study is a multisite randomized controlled trial of the effectiveness of a high-vegetable, low-fat diet, aimed at markedly raising circulating carotenoid concentrations from food sources, in reducing additional breast cancer events and early death in women with early-stage invasive breast cancer (within 4 years of diagnosis). The study randomly assigned 3088 such women to an intensive diet intervention or to a comparison group between 1995 and 2000 and is expected to follow them through 2006. Two thirds of these women were under 55 years of age at randomization. This research study has a coordinating center and seven clinical sites. Randomization was stratified by age, stage of tumor and clinical site. A comprehensive intervention program that includes intensive telephone counseling, cooking classes and print materials helps shift the dietary pattern of women in the intervention. Through an innovative telephone counseling program, dietary counselors encourage women in the intervention group to meet the following daily behavioral targets: five vegetable servings, 16 ounces of vegetable juice, three fruit servings, 30 g of fiber and 15-20% energy from fat. Adherence assessments occur at baseline, 6, 12, 24 or 36, 48 and 72 months. These assessments can include dietary intake (repeated 24-hour dietary recalls and food frequency questionnaire), circulating carotenoid concentrations, physical measures and questionnaires about health symptoms, quality of life, personal habits and lifestyle patterns. Outcome assessments are completed by telephone interview every 6 months with medical record verification. We will assess evidence of effectiveness by the length of the breast cancer event-free interval, as well as by overall survival separately in all the women in the study as well as specifically in women under and over the age of 55 years.


Journal of The American Dietetic Association | 1999

Factors Associated With Weight Gain in Women After Diagnosis of Breast Cancer

Cheryl L. Rock; Shirley W. Flatt; Vicky A. Newman; Bette J. Caan; Mary N. Haan; Marcia L. Stefanick; Susan Faerber; John P. Pierce

OBJECTIVE To identify the factors associated with weight gain after diagnosis of breast cancer in a heterogeneous population of women. DESIGN Descriptive cross-sectional study. SUBJECTS 1,116 patients who had been diagnosed with stage I, stage II, or stage IIIA primary, operable breast cancer within the previous 4 years. Patients were recruited during enrollment into a diet intervention trial to reduce risk for breast cancer recurrence. Analysis Demographic data, weight history, and physical activity information obtained by questionnaire and medical information obtained by chart review; dietary assessment based on four 24-hour dietary recalls collected by telephone. Associations between weight change after the diagnosis of breast cancer and prediction variables were examined using univariate and multiple linear regression analyses. RESULTS Overall, 60% of the subjects reported weight gain, 26% reported weight loss, and 14% reported no change in weight after the diagnosis of breast cancer. The overall mean weight change was a gain of 2.7 kg (6 lb). Factors positively and independently associated with weight gain were time since diagnosis of breast cancer, adjuvant chemotherapy, African-American ethnicity, current energy intake, and postmenopausal status at time of study entry. Factors inversely and independently associated with weight gain were prediagnosis body mass index, age at diagnosis, education level, and exercise index score. APPLICATIONS Higher energy intake and lower level of physical activity are independently associated with increased risk for weight gain after the diagnosis of breast cancer. Strategies to modify these behaviors are likely to influence the long-term pattern of weight change.


Journal of The American Dietetic Association | 1998

Dietary Supplement Use by Women at Risk for Breast Cancer Recurrence

Vicky A. Newman; Cheryl L. Rock; Susan Faerber; Shirley W. Flatt; Fred A. Wright; John P. Pierce

Abstract Objective To develop a method of collecting, organizing, and analyzing information on nutrient and nonnutrient dietary supplement use by women at risk for breast cancer recurrence as a component of nutrition assessment and monitoring, and to describe the characteristics associated with dietary supplement use in this population at enrollment in a clinical trial to prevent breast cancer recurrence. Design Cross-sectional descriptive study design. Subjects Women diagnosed with breast cancer within the previous 4 years (n=435). Analysis Dietary supplements reported in four 24-hour dietary recalls were categorized according to primary nutrient and nonnutrient contents. Prevalence of dietary supplement use is described. Associations between supplement use and demographic and participant characteristics were examined using χ 2 analysis and logistic regression. Results Dietary supplement use was reported by 80.9% of the women. Increased likelihood of supplement use was associated with demographic (eg, older age, higher level of education, white race vs other ethnic groups) and personal (eg, lower body mass index, moderate alcohol consumption) characteristics. Use of vitamin C and related compounds, other nutrients (eg, n-3 fatty acids, evening primrose oil), and herbal products was inversely associated with months since diagnosis; use of miscellaneous supplements (eg, shark cartilage) was directly associated with more advanced stage at diagnosis. Applications Monitoring dietary supplement use is an important aspect of nutrition assessment, especially in populations with chronic health conditions or medical diagnoses. Demographic and personal characteristics, time passed since diagnosis, and stage of cancer at diagnosis are predictive of dietary supplement use by women at risk for breast cancer recurrence. Associations in this population may be present in other groups that are the object of nutrition intervention efforts. J Am Diet Assoc. 1998;98:285-292.


American Journal of Obstetrics and Gynecology | 1991

Small-for-gestational-age birth: Maternal predictors and comparison with risk factors of spontaneous preterm delivery in the same cohort

Barbara Abrams; Vicky A. Newman

Low birth weight, the primary predictor of infant mortality and morbidity, can be a result of shortened gestation (preterm delivery) or fetal growth retardation (small for gestational age). We examined the relationship between maternal characteristics and the risk of delivering a small-for-gestational age infant in 2228 women who participated in the University of California, San Diego Prenatal Nutrition Project between 1978 and 1988. A multivariate analysis indicated that significant risk factors for small for gestational age were cigarette smoking (odds ratio, 3.18), a low rate of maternal weight gain (odds ratio, 2.96), black ethnicity (odds ratio, 2.60), pregravid underweight (odds ratio, 2.36), Asian ethnicity (odds ratio, 1.88), primiparity (odds ratio, 1.85), and low maternal height (odds ratio, 1.63). These findings are contrasted with those previously published on preterm deliveries in the same cohort. We conclude that with the exception of black ethnicity and low maternal weight gain, different maternal characteristics were significantly associated with small-for-gestational-age and preterm birth in this population.


Nutrition and Cancer | 1997

Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence.

John P. Pierce; Susan Faerber; Fred A. Wright; Vicky A. Newman; Shirley W. Flatt; Sheila Kealey; Cheryl L. Rock; William Hryniuk; E. Robert Greenberg

Epidemiologic evidence supports the concept that diet influences risk for breast cancer and suggests that prognosis after the diagnosis of breast cancer may also be related to modifiable nutritional factors. The purpose of this study was to investigate the feasibility of a randomized trial of a high-vegetable, reduced-fat, and increased-fiber diet intervention to reduce risk for recurrence among breast cancer survivors. This major change in dietary pattern was promoted through intensive telephone counseling. Participants were 93 women who had been diagnosed with breast cancer (stages I, II, and IIIA) within the previous four years and who had completed their initial treatment. We assessed adherence to the study diet using repeated 24-hour dietary recalls at 6 and 12 months and measurement of circulating carotenoid concentrations. Six months after randomization, the intervention group had significantly increased their mean intake of vegetables (+4.6 servings/day), fruit (+0.7 servings/day), and fiber (+6.4 g/1,000 kcal) and significantly reduced their intake of dietary fat (-9.9% of energy) compared with the control group. Circulating concentrations of carotenoids also increased in the intervention group. These changes persisted at the 12-month visit. Results of this study demonstrate that telephone counseling can be a useful approach in diet intervention and that breast cancer survivors can adopt and maintain a high-vegetable, reduced-fat dietary pattern.


Journal of The American Dietetic Association | 2002

Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer

Cynthia A. Thomson; Shirley W. Flatt; Cheryl L. Rock; Cheryl Ritenbaugh; Vicky A. Newman; John P. Pierce

OBJECTIVE To describe the dietary intake patterns of women before and after breast cancer diagnosis. SUBJECTS AND SETTING 3,084 women (age range 27 to 70 years) who had been treated for early-stage breast cancer, who were free of recurrent disease, and who were willing to complete study questionnaires. DESIGN A descriptive analysis of baseline demographic and lifestyle questionnaire data, including reported dietary intake data from women who have had breast cancer participating in a randomized, controlled dietary intervention trial. Outcomes include dietary intakes of high- and low-fat foods, fruits and vegetables, and whole grains. STATISTICAL ANALYSIS PERFORMED Analyses included frequency of intake of selected food items, chi2 analysis to determine associations between reported intakes and demographic and personal characteristics, and logistic regression to assess odds of making more healthful changes. RESULTS Women who have had breast cancer reported higher fruit, vegetable, and fiber-rich food intakes (58%, 60%, 38% more, respectively) and lower intakes of high-fat foods, including fast foods, after diagnosis. Those older than age 60 years were more likely to report no change in intake, including red meat (41%), vegetables (51%), and whole grains (62%). Odds ratios (OR) for more healthful diet choices varied by age and time since diagnosis. The longer the time since diagnosis the more likely women selected low-fat (vs high-fat) foods (OR 1.56, 95% confidence interval [CI] 1.16-2.09 for 3 to 4 years vs <1 year after diagnosis) and reduced added fats (OR 1.47, 95% CI 1.17-1.84 for 3 to 4 years vs <1 year after diagnosis). APPLICATIONS Women who have had breast cancer report more healthful diet habits after diagnosis. Through nutrition education and counseling, dietetics professionals may be able to promote healthful and evidence-based eating habits among women previously treated for breast cancer.


Journal of Clinical Oncology | 2005

Plasma Carotenoids and Recurrence-Free Survival in Women With a History of Breast Cancer

Cheryl L. Rock; Shirley W. Flatt; Loki Natarajan; Cynthia A. Thomson; Wayne A. Bardwell; Vicky A. Newman; Kathy Hollenbach; Lovell A. Jones; Bette Caan; John P. Pierce

PURPOSE Previous studies suggest that diet may affect recurrence or survival rates in women who have been diagnosed with breast cancer. The purpose of this study was to examine the relationship between plasma carotenoid concentration, as a biomarker of vegetable and fruit intake, and risk for a new breast cancer event in a cohort of women with a history of early-stage breast cancer. METHODS Participants were 1,551 women previously treated for breast cancer who were randomly assigned to the control arm of a diet intervention trial between March 1995 and November 2000. Outcome events were probed during semiannual interviews and verified by medical record review. During the period under study, 205 women had a recurrence or new primary breast cancer. Plasma carotenoid concentrations were measured in baseline blood samples. Hazard ratios (HR) and 95% CIs by quartiles of plasma carotenoids were computed, controlling for tumor stage, grade, and hormone receptor status; chemotherapy and tamoxifen therapy; clinical site; age at diagnosis; body mass index; and plasma cholesterol concentration. RESULTS Women in the highest quartile of plasma total carotenoid concentration had significantly reduced risk for a new breast cancer event (HR, 0.57; 95% CI, 0.37 to 0.89), controlled for covariates influencing breast cancer prognosis. CONCLUSION Plasma carotenoids are a biologic marker of intake of vegetables and fruit, so this observation supports findings from previous studies that have linked increased vegetable and fruit intake with greater likelihood of recurrence-free survival in women who have been diagnosed with early-stage breast cancer.


Journal of Clinical Oncology | 2004

Effects of a High-Fiber, Low-Fat Diet Intervention on Serum Concentrations of Reproductive Steroid Hormones in Women With a History of Breast Cancer

Cheryl L. Rock; Shirley W. Flatt; Cynthia A. Thomson; Marcia L. Stefanick; Vicky A. Newman; Lovell A. Jones; Loki Natarajan; Cheryl Ritenbaugh; Kathryn A. Hollenbach; John P. Pierce; R. Jeffrey Chang

PURPOSE Diet intervention trials are testing whether postdiagnosis dietary modification can influence breast cancer recurrence and survival. One possible mechanism is an effect on reproductive steroid hormones. PARTICIPANTS AND METHODS Serum reproductive steroid hormones were measured at enrollment and 1 year in 291 women with a history of breast cancer who were enrolled onto a randomized, controlled diet intervention trial. Dietary goals for the intervention group were increased fiber, vegetable, and fruit intakes and reduced fat intake. Estradiol, bioavailable estradiol, estrone, estrone sulfate, androstenedione, testosterone, dehydroepiandrosterone sulfate, follicle-stimulating hormone, and sex hormone-binding globulin were measured. RESULTS The intervention (but not the comparison) group reported a significantly lower intake of energy from fat (21% v 28%), and higher intake of fiber (29 g/d v 22 g/d), at 1-year follow-up (P <.001). Significant weight loss did not occur in either group. A significant difference in the change in bioavailable estradiol concentration from baseline to 1 year in the intervention (-13 pmol/L) versus the comparison (+3 pmol/L) group was observed (P <.05). Change in fiber (but not fat) intake was significantly and independently related to change in serum bioavailable estradiol (P <.01) and total estradiol (P <.05) concentrations. CONCLUSION Results from this study indicate that a high-fiber, low-fat diet intervention is associated with reduced serum bioavailable estradiol concentration in women diagnosed with breast cancer, the majority of whom did not exhibit weight loss. Increased fiber intake was independently related to the reduction in serum estradiol concentration.


Cancer Epidemiology, Biomarkers & Prevention | 2011

Soy Food Consumption and Breast Cancer Prognosis

Bette J. Caan; Loki Natarajan; Barbara A. Parker; Ellen B. Gold; Cynthia A. Thomson; Vicky A. Newman; Cheryl L. Rock; Minya Pu; Wael K. Al-Delaimy; John P. Pierce

Background: Contrary to earlier clinical studies suggesting that soy may promote breast tumor growth, two recent studies show that soy-containing foods are not adversely related to breast cancer prognosis. We examined, using data from the Womens Healthy Eating and Living (WHEL) study, the effect of soy intake on breast cancer prognosis. Methods: Three thousand eighty-eight breast cancer survivors, diagnosed between 1991 and 2000 with early-stage breast cancer and participating in WHEL, were followed for a median of 7.3 years. Isoflavone intakes were measured postdiagnosis by using a food frequency questionnaire. Women self-reported new outcome events semiannually, which were then verified by medical records and/or death certificates. HRs and 95% CIs representing the association between either a second breast cancer event or death and soy intake were computed, adjusting for study group and other covariates, using the delayed entry Cox proportional hazards model. Results: As isoflavone intake increased, risk of death decreased (P for trend = 0.02). Women at the highest levels of isoflavone intake (>16.3 mg isoflavones) had a nonsignificant 54% reduction in risk of death. Conclusion: Our study is the third epidemiologic study to report no adverse effects of soy foods on breast cancer prognosis. Impact: These studies, taken together, which vary in ethnic composition (two from the United States and one from China) and by level and type of soy consumption, provide the necessary epidemiologic evidence that clinicians no longer need to advise against soy consumption for women with a diagnosis of breast cancer. Cancer Epidemiol Biomarkers Prev; 20(5); 854–8. ©2011 AACR.

Collaboration


Dive into the Vicky A. Newman's collaboration.

Top Co-Authors

Avatar

John P. Pierce

University of California

View shared research outputs
Top Co-Authors

Avatar

Cheryl L. Rock

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Loki Natarajan

University of California

View shared research outputs
Top Co-Authors

Avatar

Bette J. Caan

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Susan Faerber

University of California

View shared research outputs
Top Co-Authors

Avatar

James R. Marshall

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge